![]() |
Trials |
Dose-escalating safety trial of tissue factor specific antibody drug conjugate (Humax®-TF-ADC) in patients with locally advanced and/or metastatic solid tumors known to express tissue factorCancer type: Solide tumores Phase: I Principal Investigator: Lassen Ulrik Country: DK Keywords: Denmark, Rigshospitalet, TF-ADC Status: Completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02552121?term=GEN702&rank=1 |